Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)
January 20, 2023 16:00 ET | Bernstein Liebhard LLP
Did you lose money on investments in Y-mAbs Therapeutics? If so, please visit Y-mAbs Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for LUV, ESS, and YMAB: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 20, 2023 13:01 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 20, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
johnson fistel.jpg
Y-maBs Therapeutics Class Action Lawsuit Announced: Johnson Fistel Encourages Shareholders to Submit Their Information
January 18, 2023 18:16 ET | Johnson Fistel, LLP
SAN DIEGO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Y-mAbs Therapeutics, Inc....
YMAB Investor Alert:
YMAB Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Y-mAbs Therapeutics, Inc.
November 11, 2022 20:00 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( is investigating claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the...
Block & Leviton LLP Logo
Y-mAbs Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
October 26, 2022 14:53 ET | Block & Leviton LLP
BOSTON , Oct. 26, 2022 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) for potential securities law violations. Investors who have lost money in...
Bragar Eagel & Squire, P.C. Is Investigating Evolus, Lizhi, Iovance Biotherapeutics, and Y-mAbs Therapeutics and Encourages Investors to Contact the Firm
October 09, 2020 21:00 ET | Bragar Eagel & Squire
NEW YORK, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against on behalf of investors of Evolus,...